发明申请
US20130059299A1 ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND TRANSLATION PRODUCTS AND HYBRIDIZATION PROBES THEREFORE
有权
ABERRANT MITOCHONDRIAL DNA，相关融合转录物和翻译产物及其混合物探针
- 专利标题： ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND TRANSLATION PRODUCTS AND HYBRIDIZATION PROBES THEREFORE
- 专利标题（中）： ABERRANT MITOCHONDRIAL DNA，相关融合转录物和翻译产物及其混合物探针
-
申请号： US13260497申请日： 2010-03-29
-
公开(公告)号： US20130059299A1公开(公告)日： 2013-03-07
- 发明人: Ryan Parr , Gabriel Dakubo , Andrew Harbottle , Brian Reguly , Jennifer Creed , Kerry Robinson , Daniel Klein
- 申请人： Ryan Parr , Andrew Harbottle , Brian Reguly , Jennifer Creed , Kerry Robinson , Daniel Klein
- 申请人地址： CA ON Thunder Bay
- 专利权人： MITOMICS INC.
- 当前专利权人： MITOMICS INC.
- 当前专利权人地址： CA ON Thunder Bay
- 优先权： CAPCTCA2009/000351 20090327
- 国际申请： PCT/CA2010/000423 WO 20100329
- 主分类号： G01N33/574
- IPC分类号： G01N33/574 ; C07H21/02 ; C07K16/18 ; C12Q1/68 ; C07K14/00 ; C12Q1/37 ; C07H21/04
摘要：
The present invention provides novel mitochondrial fusion transcripts, the parent mutated mtDNA molecules, and the resulting translation products (proteins) for predicting, diagnosing and/or monitoring cancer. Hybridization probes complementary thereto for use in the methods of the invention are also provided.
公开/授权文献
信息查询
IPC分类:
